Bacteremia  >>  Cubicin (daptomycin)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT00296049: Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy

Withdrawn
N/A
0
US
daptomycin, vancomycin
Wake Forest University Health Sciences, National Cancer Institute (NCI)
Infection, Neutropenia, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
03/06
03/06
NCT01219114: Safety and Efficacy Study of CUBICIN (Daptomycin) Under Conditions of Actual Use

Withdrawn
N/A
200
RoW
AstraZeneca
Complicated Skin and Skin Structure Infections and Bacteremia Including Right-sided Endocarditis
10/13
11/13

Download Options